Blockchain Technology in Healthcare Market, by Application (Supply Chain Management, Clinical Data Exchange and Interoperability, Claims Adjudication and Billing Management, and Others), by End User (Pharmaceutical Companies Healthcare Providers, Healthcare Payers, and Others) by Region (United States, Canada, Mexico, France, The UK, Spain, Germany, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Brazil, Argentina, Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) — Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019–2027
Market Overview/Industry Trends
Blockchain technology refers to the transparent and publicly reachable ledger that enable users to securely transmit the ownership of units of value by means of public-key encryption. The ability of blockchain technology to use decentralized consensus in order to maintain the network is among the key factors contributing to the increasing adoption of this technology across various industries, such as healthcare, financial services, energy & utilities, and retail amongst others. In addition, as the network is growing, technology is becoming increasingly decentralized to provide a peer-to-peer network, which is synchronized through consensus protocols. Challenges associated with data interoperability among industries is another factor considered in the increased adoption of blockchain technology in recent years. In the healthcare industry, improved healthcare interoperability is a key priority for healthcare providers, payers, policymakers, and patients in order to match an individual to his/her health data for medical care, which in turn is driving the adoption of blockchain technology in healthcare market.
The blockchain technology has been increasingly utilized within the healthcare industry to cater to the applications associated with supply chain management, claims adjudication and billing management, and healthcare regime obedience tracking amongst others. In 2013 the Food and Drug Administration (FDA) enacted the Drug Supply Chain Security Act (DSCSA) interoperability pilot with an aim to determine the ability of blockchain technology to effectively track and trace prescription drugs throughout the supply chain. This is helping FDA to protect consumers from exposure to counterfeit, filched, and contaminated drugs along with establishing national licensure standards for third-party logistics providers and wholesale distributors. Furthermore, the interoperability pilot leverages blockchain technology to support the protection of patients and patient safety along with enabling user’s ability to effectively identify, investigate, and interconnect about a pertinent suspect or illegitimate drug product. Such factors are generating opportunities for the implementation of blockchain technology in healthcare market.
The necessity of better data sharing among healthcare providers results in a higher possibility of accurate diagnoses, effective treatments, and the increased ability of healthcare organizations to provide cost-effective care. In addition, blockchain technology is further aiding healthcare providers and payers in managing medical records and trial data coupled with preserving personal privacy of patients and regulatory compliance. Moreover, the ability of blockchain technology to deliver more secure and transparent monitoring of transactions has resulted in the increased adoption of the technology to cater to the applications associated with supply chain management. Initiatives taken by pharmaceutical companies to join hands with matured blockchain tech firms in order to design, implement, manage, and maintain their drug supply chains is further expected to propel the market. For instance, in 2018, GlaxoSmithKline plc collaborated with blockchain company Viant with an aim to enable the adoption and use of the track-and-track technology to secure pharma supply chain. In 2017, Hashed Health, partnered with Accenture, Spectrum Health, WellCare, Hardenbergh Group, and national government services to create a blockchain-powered credentialing system for physicians. The credentialing system acts as an exchange platform for hospitals and other healthcare institutions that provides access to verified credential information that can be shared with all other healthcare organizations. Adoption of blockchain technology in the healthcare industry is expected to reduce the costs associated with data breaching, IT costs, personnel costs, operations costs, and support function costs through decline in frauds and counterfeit products. Ultimately, blockchain technology assist doctors and healthcare organizations alike to save time and be compliant. Thus, improved traceability of medicines, secured information shared between different entities, and improved finance and payments are some of the major factors that are projected to propel the blockchain technology in healthcare market during the forecast period.
In terms of revenue, the global blockchain technology in healthcare market was estimated to be US$ 633.99 Mn in 2018 and is expected to reach US$ 2,464.50 Mn by 2027 growing at a CAGR of 16.34% over the forecast period. The study analyzes the market in terms of revenue across all the major regions, which has been further bifurcated into countries.
Blockchain Technology in Healthcare Market Revenue & Forecast, (US$ Million), 2015–2027
Application Outlook:
Based on application, supply chain management segment for the blockchain technology in healthcare market accounted for the major market share in 2018. This can be accredited to the shift of pharmaceutical companies and healthcare providers on blockchain technology with an aim to tackle the complexities and risks associated with the healthcare supply chain. Adoption of blockchain technology in healthcare supply chain management aims to improve the security, integrity, functionality, and data provenance among pharmaceutical companies. In addition, failures in the health supply chain demonstrated by the transnational trade in fake medicines, medicine shortages, stock-outs, and security vulnerabilities in connected medical devices are some of the key factors pushing healthcare providers and pharmaceutical companies to opt for blockchain technology into their workspaces.
Moving beyond the pharmaceuticals and drug supply chain, the blockchain technology is commencing to mature in other healthcare verticals including, clinical trial stakeholders, claims adjudication, healthcare records, billing, and data management, providers. Over the period of the last 5 years, the healthcare industry has perceived a substantial adoption of electronic health records (EHRs) in order to overcome the challenges associated with healthcare data standards and insufficient privacy laws. This has generated opportunities for healthcare providers, payers, vendors, and patients to manage and maintain the seamless flow of information associated with the exchange of data between disparate systems. Thus, such factors are projected to create a positive impact on the growth of blockchain technology in healthcare market during the forecast period.
End User Outlook:
On the basis of end-user, blockchain technology in healthcare market is segregated into pharmaceutical companies, healthcare payers, healthcare providers, and others (medical technology companies and service providers). Rising incidences of supply chain data breaches is pushing pharmaceutical companies to leverage the benefits of blockchain technology to secure healthcare information and transportation flow of drugs and medical devices. In addition, the adoption of blockchain technology enables pharmaceutical companies to enhance the pharmaceutical supply chain by providing immutability and inherent transparency of the overall supply chain of drugs and medical devices, thereby eradicating the adverse events of supply chain breaches.
Growing adoption of Internet of things (IoT) devices in the healthcare industry in order to maintain seamless flow of information, which can be accessed through disparate systems is among the major factors contributing to the growth of healthcare providers in the blockchain technology in healthcare market. In addition, the ability of blockchain technology to determine the overall costs of patient care to healthcare providers through a single, immutable copy of health data shared is projected to propel the market in upcoming years.
Regional Outlook:
North America has been at the forefront of adopting novel technologies in blockchain technology in healthcare market. In addition, growing instances of wholesalers returning the drugs to the pharmaceutical manufacturers have pushed the regulatory bodies and government agencies to verify the authenticity of returned drugs and re-sell them. For instance, the Drug Supply Chain Security Act (DSCSA) in the U.S., in 2018, instructed that the drug manufacturers must implement barcoding or serialization of drugs at a package level. These serial numbers are used to verify the authenticity of the returned drugs.
In Europe, the affiliation of blockchain technology and general data protection regulation (GDPR) is benefiting the healthcare industry as it has resulted in efficient data portability, lawful access auditability, data traceability, and consent management. In 2019, the regulatory enactment called the Falsified Medicine Directive (FMD) in Europe has pushed the pharmaceutical companies to serialize or put barcodes on the drugs. Furthermore, EU has a centralized approach that allows drug manufacturers to upload serial numbers of drugs to a centralized EU regulator’s database to verify drug authenticity, which is projected to positively impact the growth of the region in the blockchain technology in healthcare market.
Competitive Landscape
The report provides both, qualitative and quantitative research of blockchain technology in healthcare market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others. Some of the key market participants in the blockchain technology in healthcare market are NTT DATA, Inc., IBM Corp., Microsoft, Tata Consultancy Services Limited, The Linux Foundation (Hyperledger), Nebula Genomics, Hashed Health, and SimplyVital Health, amongst others.
Global Blockchain Technology in Healthcare Market:
- By Application
- Supply Chain Management
- Clinical Data Exchange and Interoperability
- Claims Adjudication and Billing Management
- Others (Research & Development, Healthcare Regime Obedience Tracking, etc.)
- By End User
- Pharmaceutical Company
- Healthcare Payers
- Healthcare Providers
- Others (Medical Technology Companies, Service Providers, etc.)
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Blockchain Technology in Healthcare in
Healthcare Market
6. Market Synopsis:
Blockchain Technology in Healthcare in Healthcare Market
7. Blockchain Technology in Healthcare in Healthcare Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Blockchain Technology in Healthcare in Healthcare Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Blockchain Technology in Healthcare in
Healthcare Market
7.6. Porter’s
Five Force Analysis
8. Global Blockchain Technology in Healthcare in Healthcare
Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn)
8.2. Global
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn) and
Forecasts, By Application
8.2.1. Supply
Chain Management
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 – 2018
8.2.1.3. Market Forecast, 2019 – 2027
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market Estimation, 2015 – 2018
8.2.1.5.1.2. Market Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 – 2018
8.2.1.5.2.2. Market Forecast, 2019 – 2027
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market Estimation, 2015 – 2018
8.2.1.5.3.2. Market Forecast, 2019 – 2027
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market Estimation, 2015 – 2018
8.2.1.5.4.2. Market Forecast, 2019 – 2027
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market Estimation, 2015 – 2018
8.2.1.5.5.2. Market Forecast, 2019 – 2027
8.2.2. Clinical
Data Exchange and Interoperability
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 – 2018
8.2.2.3. Market Forecast, 2019 – 2027
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market Estimation, 2015 – 2018
8.2.2.5.1.2. Market Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 – 2018
8.2.2.5.2.2. Market Forecast, 2019 – 2027
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market Estimation, 2015 – 2018
8.2.2.5.3.2. Market Forecast, 2019 – 2027
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market Estimation, 2015 – 2018
8.2.2.5.4.2. Market Forecast, 2019 – 2027
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market Estimation, 2015 – 2018
8.2.2.5.5.2. Market Forecast, 2019 – 2027
8.2.3. Claims
Adjudication and Billing Management
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 – 2018
8.2.3.3. Market Forecast, 2019 – 2027
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market Estimation, 2015 – 2018
8.2.3.5.1.2. Market Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market Estimation, 2015 – 2018
8.2.3.5.2.2. Market Forecast, 2019 – 2027
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market Estimation, 2015 – 2018
8.2.3.5.3.2. Market Forecast, 2019 – 2027
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market Estimation, 2015 – 2018
8.2.3.5.4.2. Market Forecast, 2019 – 2027
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market Estimation, 2015 – 2018
8.2.3.5.5.2. Market Forecast, 2019 – 2027
8.2.4. Others
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 – 2018
8.2.4.3. Market Forecast, 2019 – 2027
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market Estimation, 2015 – 2018
8.2.4.5.1.2. Market Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market Estimation, 2015 – 2018
8.2.4.5.2.2. Market Forecast, 2019 – 2027
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market Estimation, 2015 – 2018
8.2.4.5.3.2. Market Forecast, 2019 – 2027
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market Estimation, 2015 – 2018
8.2.4.5.4.2. Market Forecast, 2019 – 2027
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market Estimation, 2015 – 2018
8.2.4.5.5.2. Market Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9. Global Blockchain Technology in Healthcare in Healthcare
Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Blockchain
Technology in Healthcare in Healthcare Market Revenue (US$ Mn) and Forecasts,
By End User
9.2.1. Pharmaceutical
Companies
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 – 2018
9.2.1.3. Market Forecast, 2019 – 2027
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 – 2018
9.2.1.5.1.2. Market Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 – 2018
9.2.1.5.2.2. Market Forecast, 2019 – 2027
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 – 2018
9.2.1.5.3.2. Market Forecast, 2019 – 2027
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 – 2018
9.2.1.5.4.2. Market Forecast, 2019 – 2027
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 – 2018
9.2.1.5.5.2. Market Forecast, 2019 – 2027
9.2.2. Healthcare
Providers
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 – 2018
9.2.2.3. Market Forecast, 2019 – 2027
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 – 2018
9.2.2.5.1.2. Market Forecast, 2019 – 2027
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 – 2018
9.2.2.5.2.2. Market Forecast, 2019 – 2027
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 – 2018
9.2.2.5.3.2. Market Forecast, 2019 – 2027
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 – 2018
9.2.2.5.4.2. Market Forecast, 2019 – 2027
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 – 2018
9.2.2.5.5.2. Market Forecast, 2019 – 2027
9.2.3. Healthcare
Payers
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 – 2018
9.2.3.3. Market Forecast, 2019 – 2027
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 – 2018
9.2.3.5.1.2. Market Forecast, 2019 – 2027
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 – 2018
9.2.3.5.2.2. Market Forecast, 2019 – 2027
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 – 2018
9.2.3.5.3.2. Market Forecast, 2019 – 2027
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 – 2018
9.2.3.5.4.2. Market Forecast, 2019 – 2027
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 – 2018
9.2.3.5.5.2. Market Forecast, 2019 – 2027
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 – 2018
9.2.4.3. Market Forecast, 2019 – 2027
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market Estimation, 2015 – 2018
9.2.4.5.1.2. Market Forecast, 2019 – 2027
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 – 2018
9.2.4.5.2.2. Market Forecast, 2019 – 2027
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market Estimation, 2015 – 2018
9.2.4.5.3.2. Market Forecast, 2019 – 2027
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market Estimation, 2015 – 2018
9.2.4.5.4.2. Market Forecast, 2019 – 2027
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market Estimation, 2015 – 2018
9.2.4.5.5.2. Market Forecast, 2019 – 2027
9.3. Key
Segment for Channeling Investments
9.3.1. By End
User
10. North America Blockchain Technology in Healthcare in
Healthcare Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. North
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn)
10.2. North
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Application
10.2.1. Supply
Chain Management
10.2.2. Clinical
Data Exchange and Interoperability
10.2.3. Claims
Adjudication and Billing Management
10.2.4. Others
10.3. North
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By End User
10.3.1. Pharmaceutical
Companies
10.3.2. Healthcare
Providers
10.3.3. Healthcare
Payers
10.3.4. Others
10.4. North
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Country
10.4.1. U.S
10.4.1.1. U.S Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
10.4.1.1.1. Supply Chain Management
10.4.1.1.2. Clinical Data Exchange and Interoperability
10.4.1.1.3. Claims Adjudication and Billing Management
10.4.1.1.4. Others
10.4.1.2. U.S Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
10.4.1.2.1. Pharmaceutical Companies
10.4.1.2.2. Healthcare Providers
10.4.1.2.3. Healthcare Payers
10.4.1.2.4. Others
10.4.2. Canada
10.4.2.1. Canada Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
10.4.2.1.1. Supply Chain Management
10.4.2.1.2. Clinical Data Exchange and Interoperability
10.4.2.1.3. Claims Adjudication and Billing Management
10.4.2.1.4. Others
10.4.2.2. Canada Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
10.4.2.2.1. Pharmaceutical Companies
10.4.2.2.2. Healthcare Providers
10.4.2.2.3. Healthcare Payers
10.4.2.2.4. Others
10.4.3. Mexico
10.4.3.1. Mexico Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
10.4.3.1.1. Supply Chain Management
10.4.3.1.2. Clinical Data Exchange and Interoperability
10.4.3.1.3. Claims Adjudication and Billing Management
10.4.3.1.4. Others
10.4.3.2. Mexico Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
10.4.3.2.1. Pharmaceutical Companies
10.4.3.2.2. Healthcare Providers
10.4.3.2.3. Healthcare Payers
10.4.3.2.4. Others
10.4.4. Rest of
North America
10.4.4.1. Rest of North America Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
10.4.4.1.1. Supply Chain Management
10.4.4.1.2. Clinical Data Exchange and Interoperability
10.4.4.1.3. Claims Adjudication and Billing Management
10.4.4.1.4. Others
10.4.4.2. Rest of North America Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
10.4.4.2.1. Pharmaceutical Companies
10.4.4.2.2. Healthcare Providers
10.4.4.2.3. Healthcare Payers
10.4.4.2.4. Others
10.5. Key
Segment for Channeling Investments
10.5.1. By
Country
10.5.2. By
Application
10.5.3. By End
User
11. Europe Blockchain Technology in Healthcare in Healthcare
Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1. Europe
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn)
11.2. Europe
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn) and
Forecasts, By Application
11.2.1. Supply
Chain Management
11.2.2. Clinical
Data Exchange and Interoperability
11.2.3. Claims
Adjudication and Billing Management
11.2.4. Others
11.3. Europe
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn) and
Forecasts, By End User
11.3.1. Pharmaceutical
Companies
11.3.2. Healthcare
Providers
11.3.3. Healthcare
Payers
11.3.4. Others
11.4. Europe
Blockchain Technology in Healthcare in Healthcare Market Revenue (US$ Mn) and
Forecasts, By Country
11.4.1. France
11.4.1.1. France Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
11.4.1.1.1. Supply Chain Management
11.4.1.1.2. Clinical Data Exchange and Interoperability
11.4.1.1.3. Claims Adjudication and Billing Management
11.4.1.1.4. Others
11.4.1.2. France Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
11.4.1.2.1. Pharmaceutical Companies
11.4.1.2.2. Healthcare Providers
11.4.1.2.3. Healthcare Payers
11.4.1.2.4. Others
11.4.2. The UK
11.4.2.1. The UK Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
11.4.2.1.1. Supply Chain Management
11.4.2.1.2. Clinical Data Exchange and Interoperability
11.4.2.1.3. Claims Adjudication and Billing Management
11.4.2.1.4. Others
11.4.2.2. The UK Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
11.4.2.2.1. Pharmaceutical Companies
11.4.2.2.2. Healthcare Providers
11.4.2.2.3. Healthcare Payers
11.4.2.2.4. Others
11.4.3. Spain
11.4.3.1. Spain Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
11.4.3.1.1. Supply Chain Management
11.4.3.1.2. Clinical Data Exchange and Interoperability
11.4.3.1.3. Claims Adjudication and Billing Management
11.4.3.1.4. Others
11.4.3.2. Spain Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
11.4.3.2.1. Pharmaceutical Companies
11.4.3.2.2. Healthcare Providers
11.4.3.2.3. Healthcare Payers
11.4.3.2.4. Others
11.4.4. Germany
11.4.4.1. Germany Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
11.4.4.1.1. Supply Chain Management
11.4.4.1.2. Clinical Data Exchange and Interoperability
11.4.4.1.3. Claims Adjudication and Billing Management
11.4.4.1.4. Others
11.4.4.2. Germany Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
11.4.4.2.1. Pharmaceutical Companies
11.4.4.2.2. Healthcare Providers
11.4.4.2.3. Healthcare Payers
11.4.4.2.4. Others
11.4.5. Italy
11.4.5.1. Italy Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
11.4.5.1.1. Supply Chain Management
11.4.5.1.2. Clinical Data Exchange and Interoperability
11.4.5.1.3. Claims Adjudication and Billing Management
11.4.5.1.4. Others
11.4.5.2. Italy Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
11.4.5.2.1. Pharmaceutical Companies
11.4.5.2.2. Healthcare Providers
11.4.5.2.3. Healthcare Payers
11.4.5.2.4. Others
11.4.6. Nordic
Countries
11.4.6.1. Nordic Countries Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.4.6.1.1. Supply Chain Management
11.4.6.1.2. Clinical Data Exchange and Interoperability
11.4.6.1.3. Claims Adjudication and Billing Management
11.4.6.1.4. Others
11.4.6.2. Nordic Countries Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
11.4.6.2.1. Pharmaceutical Companies
11.4.6.2.2. Healthcare Providers
11.4.6.2.3. Healthcare Payers
11.4.6.2.4. Others
11.4.6.3. Nordic Countries Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
11.4.6.3.1. Denmark
11.4.6.3.2. Finland
11.4.6.3.3. Iceland
11.4.6.3.4. Sweden
11.4.6.3.5. Norway
11.4.7. Benelux
Union
11.4.7.1. Benelux Union Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.4.7.1.1. Supply Chain Management
11.4.7.1.2. Clinical Data Exchange and Interoperability
11.4.7.1.3. Claims Adjudication and Billing Management
11.4.7.1.4. Others
11.4.7.2. Benelux Union Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
11.4.7.2.1. Pharmaceutical Companies
11.4.7.2.2. Healthcare Providers
11.4.7.2.3. Healthcare Payers
11.4.7.2.4. Others
11.4.7.3. Benelux Union Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
11.4.7.3.1. Belgium
11.4.7.3.2. The Netherlands
11.4.7.3.3. Luxembourg
11.4.8. Rest of
Europe
11.4.8.1. Rest of Europe Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
11.4.8.1.1. Supply Chain Management
11.4.8.1.2. Clinical Data Exchange and Interoperability
11.4.8.1.3. Claims Adjudication and Billing Management
11.4.8.1.4. Others
11.4.8.2. Rest of Europe Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
11.4.8.2.1. Pharmaceutical Companies
11.4.8.2.2. Healthcare Providers
11.4.8.2.3. Healthcare Payers
11.4.8.2.4. Others
11.5. Key
Segment for Channeling Investments
11.5.1. By
Country
11.5.2. By
Application
11.5.3. By End
User
12. Asia Pacific Blockchain Technology in Healthcare in
Healthcare Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Asia
Pacific Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn)
12.2. Asia
Pacific Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Application
12.2.1. Supply
Chain Management
12.2.2. Clinical
Data Exchange and Interoperability
12.2.3. Claims
Adjudication and Billing Management
12.2.4. Others
12.3. Asia
Pacific Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By End User
12.3.1. Pharmaceutical
Companies
12.3.2. Healthcare
Providers
12.3.3. Healthcare
Payers
12.3.4. Others
12.4. Asia
Pacific Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Country
12.4.1. China
12.4.1.1. China Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.1.1.1. Supply Chain Management
12.4.1.1.2. Clinical Data Exchange and Interoperability
12.4.1.1.3. Claims Adjudication and Billing Management
12.4.1.1.4. Others
12.4.1.2. China Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
12.4.1.2.1. Pharmaceutical Companies
12.4.1.2.2. Healthcare Providers
12.4.1.2.3. Healthcare Payers
12.4.1.2.4. Others
12.4.2. Japan
12.4.2.1. Japan Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.2.1.1. Supply Chain Management
12.4.2.1.2. Clinical Data Exchange and Interoperability
12.4.2.1.3. Claims Adjudication and Billing Management
12.4.2.1.4. Others
12.4.2.2. Japan Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
12.4.2.2.1. Pharmaceutical Companies
12.4.2.2.2. Healthcare Providers
12.4.2.2.3. Healthcare Payers
12.4.2.2.4. Others
12.4.3. India
12.4.3.1. India Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.3.1.1. Supply Chain Management
12.4.3.1.2. Clinical Data Exchange and Interoperability
12.4.3.1.3. Claims Adjudication and Billing Management
12.4.3.1.4. Others
12.4.3.2. India Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
12.4.3.2.1. Pharmaceutical Companies
12.4.3.2.2. Healthcare Providers
12.4.3.2.3. Healthcare Payers
12.4.3.2.4. Others
12.4.4. New
Zealand
12.4.4.1. New Zealand Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
12.4.4.1.1. Supply Chain Management
12.4.4.1.2. Clinical Data Exchange and Interoperability
12.4.4.1.3. Claims Adjudication and Billing Management
12.4.4.1.4. Others
12.4.4.2. New Zealand Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
12.4.4.2.1. Pharmaceutical Companies
12.4.4.2.2. Healthcare Providers
12.4.4.2.3. Healthcare Payers
12.4.4.2.4. Others
12.4.5. Australia
12.4.5.1. Australia Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
12.4.5.1.1. Supply Chain Management
12.4.5.1.2. Clinical Data Exchange and Interoperability
12.4.5.1.3. Claims Adjudication and Billing Management
12.4.5.1.4. Others
12.4.5.2. Australia Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
12.4.5.2.1. Pharmaceutical Companies
12.4.5.2.2. Healthcare Providers
12.4.5.2.3. Healthcare Payers
12.4.5.2.4. Others
12.4.6. South
Korea
12.4.6.1. South Korea Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
12.4.6.1.1. Supply Chain Management
12.4.6.1.2. Clinical Data Exchange and Interoperability
12.4.6.1.3. Claims Adjudication and Billing Management
12.4.6.1.4. Others
12.4.6.2. South Korea Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
12.4.6.2.1. Pharmaceutical Companies
12.4.6.2.2. Healthcare Providers
12.4.6.2.3. Healthcare Payers
12.4.6.2.4. Others
12.4.7. Southeast
Asia
12.4.7.1. Southeast Asia Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.4.7.1.1. Supply Chain Management
12.4.7.1.2. Clinical Data Exchange and Interoperability
12.4.7.1.3. Claims Adjudication and Billing Management
12.4.7.1.4. Others
12.4.7.2. Southeast Asia Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
12.4.7.2.1. Pharmaceutical Companies
12.4.7.2.2. Healthcare Providers
12.4.7.2.3. Healthcare Payers
12.4.7.2.4. Others
12.4.7.3. Southeast Asia Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Country
12.4.7.3.1. Indonesia
12.4.7.3.2. Thailand
12.4.7.3.3. Malaysia
12.4.7.3.4. Singapore
12.4.7.3.5. Rest of Southeast Asia
12.4.8. Rest of
Asia Pacific
12.4.8.1. Rest of Asia Pacific Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
12.4.8.1.1. Supply Chain Management
12.4.8.1.2. Clinical Data Exchange and Interoperability
12.4.8.1.3. Claims Adjudication and Billing Management
12.4.8.1.4. Others
12.4.8.2. Rest of Asia Pacific Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
12.4.8.2.1. Pharmaceutical Companies
12.4.8.2.2. Healthcare Providers
12.4.8.2.3. Healthcare Payers
12.4.8.2.4. Others
12.5. Key
Segment for Channeling Investments
12.5.1. By
Country
12.5.2. By
Application
12.5.3. By End
User
13. Middle East and Africa Blockchain Technology in Healthcare in
Healthcare Market Analysis and Forecasts, 2019 - 2027
13.1. Overview
13.1.1. Middle
East and Africa Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn)
13.2. Middle
East and Africa Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
13.2.1. Supply
Chain Management
13.2.2. Clinical
Data Exchange and Interoperability
13.2.3. Claims
Adjudication and Billing Management
13.2.4. Others
13.3. Middle
East and Africa Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
13.3.1. Pharmaceutical
Companies
13.3.2. Healthcare
Providers
13.3.3. Healthcare
Payers
13.3.4. Others
13.4. Middle
East and Africa Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Country
13.4.1. Saudi
Arabia
13.4.1.1. Saudi Arabia Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1.1.1. Supply Chain Management
13.4.1.1.2. Clinical Data Exchange and Interoperability
13.4.1.1.3. Claims Adjudication and Billing Management
13.4.1.1.4. Others
13.4.1.2. Saudi Arabia Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
13.4.1.2.1. Pharmaceutical Companies
13.4.1.2.2. Healthcare Providers
13.4.1.2.3. Healthcare Payers
13.4.1.2.4. Others
13.4.2. UAE
13.4.2.1. UAE Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
13.4.2.1.1. Supply Chain Management
13.4.2.1.2. Clinical Data Exchange and Interoperability
13.4.2.1.3. Claims Adjudication and Billing Management
13.4.2.1.4. Others
13.4.2.2. UAE Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
13.4.2.2.1. Pharmaceutical Companies
13.4.2.2.2. Healthcare Providers
13.4.2.2.3. Healthcare Payers
13.4.2.2.4. Others
13.4.3. Egypt
13.4.3.1. Egypt Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By Application
13.4.3.1.1. Supply Chain Management
13.4.3.1.2. Clinical Data Exchange and Interoperability
13.4.3.1.3. Claims Adjudication and Billing Management
13.4.3.1.4. Others
13.4.3.2. Egypt Blockchain Technology in Healthcare in Healthcare Market
Revenue (US$ Mn) and Forecasts, By End User
13.4.3.2.1. Pharmaceutical Companies
13.4.3.2.2. Healthcare Providers
13.4.3.2.3. Healthcare Payers
13.4.3.2.4. Others
13.4.4. Kuwait
13.4.4.1. Kuwait Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
13.4.4.1.1. Supply Chain Management
13.4.4.1.2. Clinical Data Exchange and Interoperability
13.4.4.1.3. Claims Adjudication and Billing Management
13.4.4.1.4. Others
13.4.4.2. Kuwait Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
13.4.4.2.1. Pharmaceutical Companies
13.4.4.2.2. Healthcare Providers
13.4.4.2.3. Healthcare Payers
13.4.4.2.4. Others
13.4.5. South
Africa
13.4.5.1. South Africa Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
13.4.5.1.1. Supply Chain Management
13.4.5.1.2. Clinical Data Exchange and Interoperability
13.4.5.1.3. Claims Adjudication and Billing Management
13.4.5.1.4. Others
13.4.5.2. South Africa Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
13.4.5.2.1. Pharmaceutical Companies
13.4.5.2.2. Healthcare Providers
13.4.5.2.3. Healthcare Payers
13.4.5.2.4. Others
13.4.6. Rest of
Middle East & Africa
13.4.6.1. Rest of Middle East & Africa Blockchain Technology in
Healthcare in Healthcare Market Revenue (US$ Mn) and Forecasts, By Application
13.4.6.1.1. Supply Chain Management
13.4.6.1.2. Clinical Data Exchange and Interoperability
13.4.6.1.3. Claims Adjudication and Billing Management
13.4.6.1.4. Others
13.4.6.2. Rest of Middle East & Africa Blockchain Technology in
Healthcare in Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
13.4.6.2.1. Pharmaceutical Companies
13.4.6.2.2. Healthcare Providers
13.4.6.2.3. Healthcare Payers
13.4.6.2.4. Others
13.5. Key
Segment for Channeling Investments
13.5.1. By
Country
13.5.2. By
Application
13.5.3. By End
User
14. Latin America Blockchain Technology in Healthcare in
Healthcare Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1. Latin
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn)
14.2. Latin
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Application
14.2.1. Supply
Chain Management
14.2.2. Clinical
Data Exchange and Interoperability
14.2.3. Claims
Adjudication and Billing Management
14.2.4. Others
14.3. Latin
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By End User
14.3.1. Pharmaceutical
Companies
14.3.2. Healthcare
Providers
14.3.3. Healthcare
Payers
14.3.4. Others
14.4. Latin
America Blockchain Technology in Healthcare in Healthcare Market Revenue (US$
Mn) and Forecasts, By Country
14.4.1. Brazil
14.4.1.1. Brazil Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1.1.1. Supply Chain Management
14.4.1.1.2. Clinical Data Exchange and Interoperability
14.4.1.1.3. Claims Adjudication and Billing Management
14.4.1.1.4. Others
14.4.1.2. Brazil Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
14.4.1.2.1. Pharmaceutical Companies
14.4.1.2.2. Healthcare Providers
14.4.1.2.3. Healthcare Payers
14.4.1.2.4. Others
14.4.2. Argentina
14.4.2.1. Argentina Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
14.4.2.1.1. Supply Chain Management
14.4.2.1.2. Clinical Data Exchange and Interoperability
14.4.2.1.3. Claims Adjudication and Billing Management
14.4.2.1.4. Others
14.4.2.2. Argentina Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By End User
14.4.2.2.1. Pharmaceutical Companies
14.4.2.2.2. Healthcare Providers
14.4.2.2.3. Healthcare Payers
14.4.2.2.4. Others
14.4.3. Rest of
Latin America
14.4.3.1. Rest of Latin America Blockchain Technology in Healthcare in Healthcare
Market Revenue (US$ Mn) and Forecasts, By Application
14.4.3.1.1. Supply Chain Management
14.4.3.1.2. Clinical Data Exchange and Interoperability
14.4.3.1.3. Claims Adjudication and Billing Management
14.4.3.1.4. Others
14.4.3.2. Rest of Latin America Blockchain Technology in Healthcare in
Healthcare Market Revenue (US$ Mn) and Forecasts, By End User
14.4.3.2.1. Pharmaceutical Companies
14.4.3.2.2. Healthcare Providers
14.4.3.2.3. Healthcare Payers
14.4.3.2.4. Others
14.5. Key
Segment for Channeling Investments
14.5.1. By
Country
14.5.2. By
Application
14.5.3. By End
User
15. Competitive Benchmarking
15.1. Brand
Benchmarking
15.2. Market
Share Analysis, 2018
15.3. Global
Presence and Growth Strategies
15.3.1. Mergers
and Acquisitions
15.3.2. Product
Launches
15.3.3. Investments
Trends
15.3.4. R&D
Initiatives
16. Player Profiles
16.1. Blockpharma
16.1.1. Company
Details
16.1.2. Company
Overview
16.1.3. Product
Offerings
16.1.4. Key
Developments
16.1.5. Financial
Analysis
16.1.6. SWOT
Analysis
16.1.7. Business
Strategies
16.2. Chronicled
16.2.1. Company
Details
16.2.2. Company
Overview
16.2.3. Product
Offerings
16.2.4. Key
Developments
16.2.5. Financial
Analysis
16.2.6. SWOT
Analysis
16.2.7. Business
Strategies
16.3. Coral
Health R&D Inc.
16.3.1. Company
Details
16.3.2. Company
Overview
16.3.3. Product
Offerings
16.3.4. Key
Developments
16.3.5. Financial
Analysis
16.3.6. SWOT
Analysis
16.3.7. Business
Strategies
16.4. Doc.ai
16.4.1. Company
Details
16.4.2. Company
Overview
16.4.3. Product
Offerings
16.4.4. Key
Developments
16.4.5. Financial
Analysis
16.4.6. SWOT
Analysis
16.4.7. Business
Strategies
16.5. ENCRYPGEN
INCORPORATED
16.5.1. Company
Details
16.5.2. Company
Overview
16.5.3. Product
Offerings
16.5.4. Key
Developments
16.5.5. Financial
Analysis
16.5.6. SWOT
Analysis
16.5.7. Business
Strategies
16.6. Factom
16.6.1. Company
Details
16.6.2. Company
Overview
16.6.3. Product
Offerings
16.6.4. Key
Developments
16.6.5. Financial
Analysis
16.6.6. SWOT
Analysis
16.6.7. Business
Strategies
16.7. Farmatrust
16.7.1. Company
Details
16.7.2. Company
Overview
16.7.3. Product
Offerings
16.7.4. Key Developments
16.7.5. Financial
Analysis
16.7.6. SWOT
Analysis
16.7.7. Business
Strategies
16.8. Gem
16.8.1. Company
Details
16.8.2. Company
Overview
16.8.3. Product
Offerings
16.8.4. Key
Developments
16.8.5. Financial
Analysis
16.8.6. SWOT
Analysis
16.8.7. Business
Strategies
16.9. Guardtime
16.9.1. Company
Details
16.9.2. Company
Overview
16.9.3. Product
Offerings
16.9.4. Key Developments
16.9.5. Financial
Analysis
16.9.6. SWOT
Analysis
16.9.7. Business
Strategies
16.10. Hashed
Health
16.10.1. Company
Details
16.10.2. Company
Overview
16.10.3. Product
Offerings
16.10.4. Key
Developments
16.10.5. Financial
Analysis
16.10.6. SWOT
Analysis
16.10.7. Business
Strategies
16.11. Health
Linkages, Inc.
16.11.1. Company
Details
16.11.2. Company
Overview
16.11.3. Product
Offerings
16.11.4. Key
Developments
16.11.5. Financial
Analysis
16.11.6. SWOT
Analysis
16.11.7. Business
Strategies
16.12. HealthCombix
16.12.1. Company
Details
16.12.2. Company
Overview
16.12.3. Product
Offerings
16.12.4. Key
Developments
16.12.5. Financial
Analysis
16.12.6. SWOT
Analysis
16.12.7. Business
Strategies
16.13. IBM
Corporation
16.13.1. Company
Details
16.13.2. Company
Overview
16.13.3. Product
Offerings
16.13.4. Key
Developments
16.13.5. Financial
Analysis
16.13.6. SWOT
Analysis
16.13.7. Business
Strategies
16.14. Iryo
d.o.o.
16.14.1. Company
Details
16.14.2. Company
Overview
16.14.3. Product
Offerings
16.14.4. Key
Developments
16.14.5. Financial
Analysis
16.14.6. SWOT
Analysis
16.14.7. Business
Strategies
16.15. iSolve,
LLC
16.15.1. Company
Details
16.15.2. Company
Overview
16.15.3. Product
Offerings
16.15.4. Key
Developments
16.15.5. Financial
Analysis
16.15.6. SWOT
Analysis
16.15.7. Business
Strategies
16.16. Medicalchain
SA
16.16.1. Company
Details
16.16.2. Company
Overview
16.16.3. Product
Offerings
16.16.4. Key
Developments
16.16.5. Financial
Analysis
16.16.6. SWOT
Analysis
16.16.7. Business
Strategies
16.17. MedRec
16.17.1. Company
Details
16.17.2. Company
Overview
16.17.3. Product
Offerings
16.17.4. Key
Developments
16.17.5. Financial
Analysis
16.17.6. SWOT
Analysis
16.17.7. Business
Strategies
16.18. Microsoft
16.18.1. Company
Details
16.18.2. Company
Overview
16.18.3. Product
Offerings
16.18.4. Key
Developments
16.18.5. Financial
Analysis
16.18.6. SWOT
Analysis
16.18.7. Business
Strategies
16.19. Nebula
Genomics
16.19.1. Company
Details
16.19.2. Company
Overview
16.19.3. Product
Offerings
16.19.4. Key
Developments
16.19.5. Financial
Analysis
16.19.6. SWOT
Analysis
16.19.7. Business
Strategies
16.20. NTT
DATA, Inc.
16.20.1. Company
Details
16.20.2. Company
Overview
16.20.3. Product
Offerings
16.20.4. Key
Developments
16.20.5. Financial
Analysis
16.20.6. SWOT
Analysis
16.20.7. Business
Strategies
16.21. Patientory
16.21.1. Company
Details
16.21.2. Company
Overview
16.21.3. Product
Offerings
16.21.4. Key
Developments
16.21.5. Financial
Analysis
16.21.6. SWOT
Analysis
16.21.7. Business
Strategies
16.22. Proof.Works
16.22.1. Company
Details
16.22.2. Company
Overview
16.22.3. Product
Offerings
16.22.4. Key
Developments
16.22.5. Financial
Analysis
16.22.6. SWOT
Analysis
16.22.7. Business
Strategies
16.23. SimplyVital
Health
16.23.1. Company
Details
16.23.2. Company
Overview
16.23.3. Product
Offerings
16.23.4. Key
Developments
16.23.5. Financial
Analysis
16.23.6. SWOT
Analysis
16.23.7. Business
Strategies
16.24. Tata
Consultancy Services Limited
16.24.1. Company
Details
16.24.2. Company
Overview
16.24.3. Product
Offerings
16.24.4. Key
Developments
16.24.5. Financial
Analysis
16.24.6. SWOT
Analysis
16.24.7. Business
Strategies
16.25. The
Linux Foundation (Hyperledger)
16.25.1. Company
Details
16.25.2. Company
Overview
16.25.3. Product
Offerings
16.25.4. Key
Developments
16.25.5. Financial
Analysis
16.25.6. SWOT
Analysis
16.25.7. Business
Strategies
16.26. Other
Market Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
